MedTrace Logo

Effect of Extracorporeal Radial Shock Wave Phonophoresis on Subacromial Space in Patients With Impingement Syndrome.

NCT07510399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-06-10

No results posted yet for this study

Summary

The goal of the study is to determine the effect of radial shock wave Phonophoresis on patients with impingement syndromes. to answer the following questions:

does shock wave Phonophoresis have and effect on pain? does shock wave Phonophoresis have and effect on shoulder function? does shock wave Phonophoresis have and effect on subacromial space? patients will be randomized to two groups: Group (A): patients will receive shock wave Phonophoresis plus conventional physical therapy.

Group (B): Patients will receive shock wave plus conventional Physical therapy.

Conditions

  • Rehabilitation
  • Shock Wave
  • Impingement Syndrome

Interventions

DEVICE

radial shock wave phonophoresis plus conventional physical therapy

patients will receive radial shock wave Phonophoresis by ibuprofen in the form of 2000 shocks, 2 bars, 8 MHz frequency plus (strengthening and stretching exercises for subraspinatus muscle).

DEVICE

radial shock wave therapy plus conventional physical therapy.

patients will receive radial shock wave therapy ( 2000 shocks, 2 bars, 8 MHz), plus conventional physical therapy (strengthening and stretching exercises for subraspinatus muscle).

Sponsors & Collaborators

  • MTI University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2026-05-10
Completion
2026-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07510399 on ClinicalTrials.gov